Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Currency
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
BerGenBio AS (BRRGF)
OTHER OTC:BRRGF
BerGenBio AS (BRRGF) Stock Price & Analysis
32 Followers
BRRGF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.17
Previous Close$0.03
Volume37.30K
Average Volume (3M)37.30K
Market Cap
$52.25M
Enterprise Value$460.07M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$407.83M
Price to Earnings (P/E)-0.7
Beta0.32
Next Earnings
Feb 14, 2024EPS Estimate
>-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding2,620,532,532
10 Day Avg. Volume3,731
30 Day Avg. Volume37,305
Standard Deviation0.60
R-Squared0.00094
Alpha-0.00157
Financial Highlights & Ratios
Price to Book (P/B)2.42
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.77
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-5.41
Forecast
1Y Price Target
$0.18Price Target Upside620.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Ownership Overview
0.00%
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
BRRGF FAQ
What was BerGenBio AS’s price range in the past 12 months?
BerGenBio AS lowest stock price was $0.02 and its highest was $0.17 in the past 12 months.
What is BerGenBio AS’s market cap?
Currently, no data Available
When is BerGenBio AS’s upcoming earnings report date?
BerGenBio AS’s upcoming earnings report date is Feb 14, 2024 which is in 66 days.
How were BerGenBio AS’s earnings last quarter?
BerGenBio AS released its earnings results on Nov 14, 2023. The company reported >-$0.001 earnings per share for the quarter, beating the consensus estimate of -$0.002 by <$0.001.
Is BerGenBio AS overvalued?
According to Wall Street analysts BerGenBio AS’s price is currently Undervalued.
Does BerGenBio AS pay dividends?
BerGenBio AS does not currently pay dividends.
What is BerGenBio AS’s EPS estimate?
BerGenBio AS’s EPS estimate is >-$0.01.
How many shares outstanding does BerGenBio AS have?
BerGenBio AS has 2,620,532,500 shares outstanding.
What happened to BerGenBio AS’s price movement after its last earnings report?
BerGenBio AS reported an EPS of >-$0.001 in its last earnings report, beating expectations of -$0.002. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BerGenBio AS?
Currently, no hedge funds are holding shares in BRRGF
---
BerGenBio AS Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.94%
12-Months-Change
Fundamentals
Return on Equity
-144.15%
Trailing 12-Months
Asset Growth
-18.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
BerGenBio AS
BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
---
---